Showing results (271-280 of 22,075) with videos related to

Sort By:
Pageof 2,208
Oncogene|May 12, 2015
USP7 is essential for maintaining Rad18 stability and DNA damage toleranceA Zlatanou, S Sabbioneda, E S Miller, et al.
Oncogene|May 12, 2015
Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategiesC Raggi, H S Mousa, M Correnti, et al.
Oncogene|May 12, 2015
p38γ MAPK is required for inflammation-associated colon tumorigenesisN Yin, X Qi, S Tsai, et al.
Oncogene|May 12, 2015
MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage responseF Mancini, L Pieroni, V Monteleone, et al.
Oncogene|July 26, 2016
The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial-to-mesenchymal transitionC Battistelli, C Cicchini, L Santangelo, et al.
Oncogene|July 26, 2016
Human EHMT2/G9a activates p53 through methylation-independent mechanismM Rada, E Vasileva, L Lezina, et al.
Oncogene|July 26, 2016
FOXM1 allows human keratinocytes to bypass the oncogene-induced differentiation checkpoint in response to gain of MYC or loss of p53R Molinuevo, A Freije, I de Pedro, et al.
Oncogene|July 4, 1998
Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytesJ J Li, J S Rhim, R Schlegel, et al.
Oncogene|July 4, 1998
Allelic loss analysis of gamma-ray-induced mouse thymic lymphomas: two candidate tumor suppressor gene loci on chromosomes 12 and 16Y Matsumoto, S Kosugi, T Shinbo, et al.
Oncogene|July 4, 1998
Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instabilityS J McCormack, Z Weaver, S Deming, et al.
Pageof 2,208